Abstract
Evaluating Drug Profitability before Market Launch using Pharmacoeconomic Data: A Study of Generic Warfarin used for Long-Term Anticoagulation
Highlights
The profitability of a new drug is an important factor that should be used for managing the drug portfolio [1]
In this paper we describe a mathematical equation for calculating the profitability of a new generic drug based on pharmaceutical medicine criteria
Based on personal clinical experience and pharmacoeconomic studies we have chosen warfarin as an example because this drug is underused in patients with atrial fibrillation for ischemic stroke prevention [3] and venous thromboembolism [4]
Summary
The profitability (i.e. revenue minus cost) of a new drug is an important factor that should be used for managing the drug portfolio [1]. The profitability of a new drug can be calculated as drug revenue minus drug cost. A pharmaceutical company can increase the profitability of a new drug by optimizing factors that influence drug consumption and drug concept to market cost.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
